Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

31901
1
LXP Industrial Trust LXP Industrial Trust Reports Mixed Financial Results, Revenue Growth Offset by Decline in Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments

31902
1
Neonode Inc. Neonode Inc. Reports Slight Revenue Decline, Continued Net Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31903
1
Royalty Pharma plc Royalty Pharma Reports Strong Operating Income and Net Income, Expands Funding Collaboration and Makes Strategic Acquisitions

Via official filing (AI summary) | over 1 year ago | 0 comments

31904
1
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Charles River Laboratories Reports Decline in Revenue and Net Income for Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31905
1
UNIFI INC Unifi, Inc. Reports Improved Revenue and Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31906
1
Greystone Housing Impact Investors LP Greystone Housing Impact Investors LP Reports 8.1% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31907
1
Claritev Corp MultiPlan Corp Reports Significant Financial Challenges in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

31908
1
TWIN DISC INC Twin Disc Reports 14.7% Revenue Growth, Net Loss in Q1 2025

Via official filing (AI summary) | over 1 year ago | 0 comments

31909
1
RHYTHM PHARMACEUTICALS, INC. Rhythm Pharmaceuticals Reports 48% Increase in Product Revenue, Net Loss Widens in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31910
1
WHITE MOUNTAINS INSURANCE GROUP LTD White Mountains Insurance Group Reports Significant Revenue and Profit Growth in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31911
1
STIFEL FINANCIAL CORP Stifel Financial Corp. Reports 16.6% Revenue Growth, 132.5% Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31912
1
SmartRent, Inc. SmartRent Reports 30% Decline in Revenue, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31913
1
ONE STOP SYSTEMS, INC. One Stop Systems Reports Challenging Financial Performance, Net Loss Widens in Q3 and Nine Months

Via official filing (AI summary) | over 1 year ago | 0 comments

31914
1
Centuri Holdings, Inc. Centuri Holdings Reports Decline in Financial Performance for Third Quarter and Nine Months Ended September 29, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31915
1
Barinthus Biotherapeutics plc. Barinthus Biotherapeutics Reports Mixed Financial Results, Shifts Focus to Key Product Candidates

Via official filing (AI summary) | over 1 year ago | 0 comments

31916
1
BlackRock TCP Capital Corp. BlackRock TCP Capital Corp. Reports Significant Financial Developments Following Merger with BlackRock Capital Investment Corporation

Via official filing (AI summary) | over 1 year ago | 0 comments

31917
1
Scienture Holdings, Inc. Scienture Holdings Reports Significant Financial Changes, Including 83% Revenue Decline and 337% Operating Expense Increase in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31918
1
CONDUENT Inc Conduent Reports 13% Revenue Decline, Turnaround in Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31919
1
Coya Therapeutics, Inc. Coya Therapeutics Reports 9-Month Financial Results, Collaboration Revenue Growth, and Strategic Advancements in Clinical Programs

Via official filing (AI summary) | over 1 year ago | 0 comments

31920
1
Coupang, Inc. Coupang Reports 27% Revenue Growth, Operating Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31921
1
NewAmsterdam Pharma Co N.V. NewAmsterdam Pharma Reports 890% Revenue Growth, Improved Operating Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31922
1
UroGen Pharma Ltd. UroGen Pharma Reports Increased Revenue and Assets, Widening Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31923
1
Praxis Precision Medicines, Inc. Praxis Precision Medicines Reports Significant Financial Developments, Increased Cash Reserves, and Ongoing Operating Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

31924
1
Paysign, Inc. Paysign, Inc. Reports 23% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31925
1
AMERICAN ELECTRIC POWER CO INC American Electric Power Reports Strong Financial Performance in Q3 2024, with Revenues and Net Income Up

Via official filing (AI summary) | over 1 year ago | 0 comments